Ranitidine
Coverage of Ranitidine in the Nexus archive.
- Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills
An over-the-counter allergy medication, cetirizine hydrochloride, sold nationwide by Unique Pharmaceutical Laboratories is being recalled due to contamination with ranitidine (Zantac). The FDA confirmed the recall, which was triggered by a pharmacy technician noticing incorrect pill colors. The mix-up could cause life-threatening reactions in individuals hypersensitive to ranitidine.
- Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills
Unique Pharmaceutical Laboratories is recalling cetirizine hydrochloride tablets (generic Zyrtec) due to contamination with ranitidine (Zantac), which could cause life-threatening reactions in hypersensitive individuals. The FDA confirmed the recall after a pharmacy technician identified wrong-colored pills in the bottles. No illnesses have been reported.
- Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills
Unique Pharmaceutical Laboratories is recalling cetirizine hydrochloride tablets, a generic allergy medication, due to contamination with ranitidine (Zantac). The recall was prompted by a pharmacy technician noticing incorrect pills, but no illnesses have been reported.
- FDA recalled generic allergy tablets that may have been mixed with a heartburn drug
The FDA has recalled four lots of cetirizine hydrochloride tablets produced by Unique Pharmaceutical Laboratories due to potential contamination with ranitidine. The heartburn drug ranitidine, if present, could cause severe allergic reactions in users.
- Recall alert: Cetirizine Hydrochloride recalled over cross-contamination
The FDA has issued a nationwide recall of four lots of Cetirizine Hydrochloride Tablets USP 5 mg produced by Unique Pharmaceuticals due to potential cross-contamination with ranitidine. The affected lots, identified by NDC 16571-401-10 and expiration dates 10/2028, may cause severe allergic reactions in individuals sensitive to ranitidine. No adverse effects have been reported, and consumers are advised to contact Rising Pharma Holdings for further information.